Banks and their total shares in the BioMarin Pharmaceuticals Inc

BioMarin Pharmaceuticals

Comerica Bank has risen its stake in the shares of the BioMarin Pharmaceutical Inc, by a percent of 26% during the first quarter according to the company’s most new filing with the SEC. After purchasing an extra 2,614 shares of the biotech company’s stock the total fund owned now 12,674 shares. Holdings of the Comerica Bank in the BioMarin Pharma were worth $1,170,000 by the end of the recent quarter.

Various other funds and other investors also either added to or reduced the stakes in BioMarin Pharmaceutical Inc. recently. Australia’s Commonwealth Bank raised its position in the BioMarin Pharmaceutical Inc. by 49.6% in the last quarter. Now the Commonwealth Bank of Australia owns a total of 350 shares of the biotech company’s stick which is valued at $29 thousand after getting the acquirement of an extra 116 shares during the 4th quarter.

Tokio Marine Asset Management Co. Limited raised its position in the BioMarin Pharmaceutical by 0.5 percent in the first quarter. At present, Tokio Marine Asset Management Co. Limited possesses 27,142 shares of the biotech company’s stock which is valued at $2,411,000 after getting the acquirement of an extra 144 shares during the 4th quarter.

First Hawaiian Bank raised its position in BioMarin Pharmaceutical Inc. by 2.3 percent in the first quarter. At present, First Hawaiian Bank possesses 8,935 shares of the biotech company’s stock which is valued at $794,000 after getting the acquirement of an extra 200 shares during the 4th quarter.

Sumitomo Mitsui Asset Management Company Limited raised its position in BioMarin Pharmaceutical Inc. by 1.9 percent in the first quarter. Currently, Sumitomo Mitsui Asset Management Company Limited possesses 10,783 shares of the biotech company’s stock which is valued at $918,000 after getting the acquirement of an extra 205 shares during the 4th quarter.